PAD

Royal Philips to acquire American developer of minimally-invasive peripheral vascular devices

(PRESS RELEASE) AMSTERDAM, 14-Dec-2021 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has…

2 years ago

Medtronic: U.S. FDA approval for HawkOne Directional Atherectomy System for patients with peripheral artery disease (PAD)

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 27-Oct-2016 —…

8 years ago